Critical Care Medicine
Adjunct Nitrous Oxide Normalizes Vascular Reactivity Changes after Hemorrhagic Shock in Mice under Isoflurane Anesthesia
Samarska, Iryna V. M.D.*; van Meurs, Matijs M.D.†; Buikema, Hendrik M.Sc., Ph.D.‡; Houwertjes, Martin C.§; Wulfert, Francis M. M.D.∥; Molema, Grietje Ph.D.#; Epema, Anne H. M.D., Ph.D.†; Henning, Robert H. M.D., Ph.D.**
Background: Hemorrhagic shock is associated with changes in vascular responsiveness that may lead to organ dysfunction and, ultimately, multiple organ dysfunction syndrome. Volatile anesthetics interfere with vasoresponsiveness, which may contribute to organ hypoperfusion. In this study, the authors examined the influence of adjunct nitrous oxide on the vascular responsiveness after short-term hemorrhagic shock under isoflurane anesthesia.
Methods: Spontaneously breathing mice (n = 31, 27.6 ± 0.31 g) were anesthetized with isoflurane (1.4%) or with isoflurane (1.4%) and adjunct nitrous oxide (66%). Both groups were divided into Sham, Shock, and Resuscitated groups. Vascular reactivity to phenylephrine and acetylcholine and expression of cyclooxygenases were studied in the aorta.
Results: In the isoflurane-anesthetized groups, the contractile response to phenylephrine was increased in the Shock as compared with the Sham and Resuscitated groups (Emax = 3.2 ± 0.4, 1.2 ± 0.4, and 2.5 ± 0.5 mN, respectively). Adjunct nitrous oxide increased phenylephrine contraction to a similar level in all three groups. In the Sham isoflurane group, acetylcholine caused a biphasic response: An initial relaxation followed by a contractile response sensitive to cyclooxygenases inhibition by indomethacine. The contractile response was abrogated in the isoflurane-anesthetized groups that underwent shock. In all groups, adjunct nitrous oxide preserved the contractile phase. Shock induced a down-regulation of cyclooxygenases-1, which was normalized by adjunct nitrous oxide.
Conclusion: Adjunct nitrous oxide attenuates shock-induced changes in vascular reactivity and cyclooxygenases expression of mice under isoflurane anesthesia. This implies that vascular reactive properties during anesthesia in hemorrhagic shock conditions may be influenced by the choice of anesthetics.
CHANGED vascular reactivity in hemorrhagic shock may represent an important factor in the development of a multiple organ dysfunction syndrome. The mechanisms underlying this syndrome are not fully understood. However, early changes in vascular responsiveness may be of significance, as arterial hypotension and vascular leakage have been recognized as hallmarks of the postshock state.1–3
Indeed, hypotension has been associated with altered vascular reactivity to different modulators of vascular tone.1
Several mechanisms have been proposed to cause postshock vascular hyporeactivity, including systemic and local release of nitric oxide, decreased plasma levels of vasopressin, and changes in properties of vascular smooth muscle cells.2–5
Patients with hemorrhagic shock frequently receive anesthesia to facilitate diagnostic and therapeutic procedures. Many of the agents employed interfere with vasoresponsiveness and/or influence the therapeutic effectiveness of vasoactive drugs and the development and outcome of hemorrhagic shock. Volatile anesthetics may evoke peripheral vasodilatation, myocardial depression, and lower sympathetic nervous system activity, subsequently leading to a decrease in blood pressure.6,7
Moreover, these agents may influence systemic secretion of vasoconstrictors such as vasopressin, angiotensin, and endothelin, further contributing to a reduction in blood pressure and deterioration of organ microcirculation.8,9
Nitrous oxide, still widely used as an adjunct in various anesthetic techniques, has also been implied to influence hemodynamics. Adjunct nitrous oxide to sevoflurane (at 1.5 minimum alveolar concentration [MAC]) or isoflurane (at 1.45 MAC) stabilizes several hemodynamic parameters of regional and systemic flow.10–12
The mechanisms through which nitrous oxide offsets the hemodynamic effects of volatile anesthetics are still not fully understood,13
although venoconstrictor effects of nitrous oxide and sympathetic stimulation have been proposed as a possible explanation.12
The purpose of this study was to determine the change in vascular responsiveness obtained from mice after short-term hemorrhagic shock under isoflurane anesthesia, and to investigate the effects of adjunct nitrous oxide administration on the observed changes.
Materials and Methods
The experimental protocol was approved by the Institutional Animal Care and Use Committee of the University of Groningen (Groningen, The Netherlands). This study was performed in 31 adult mice (27.6 ± 0.31 g; Harlan, Zeist, The Netherlands) housed under standard conditions with free access to food (standard rat chow) and drinking water throughout the study.
Experimental animals were assigned to two groups: A group of mice that were anesthetized with isoflurane (1.4%) in an oxygen/air mixture (33%), and a group of mice that were anesthetized with isoflurane (1.4%) and adjunct nitrous oxide (66%) in oxygen (33%). Each group was divided into three experimental subgroups (n = 5–6 per group). Sham animals were anesthetized and cannulated but not hemorrhaged, and kept under anesthesia for 90 min before being killed. Shock animals underwent anesthesia and hemorrhage and were sacrificed after 90 min of hemorrhagic shock. Resuscitated animals underwent anesthesia with hemorrhagic shock for 90 min, followed by resuscitation with 6% hydroxyethyl starch 130/0.4 (Voluven; Fresenius-Kabi, Bad Homburg, Germany). The resuscitation volume was twice the estimated volume of the blood withdrawn to induce hemorrhagic shock. Resuscitated mice were sacrificed 24 h after induction of shock. All animals were breathing spontaneously throughout the protocol.
A fixed–blood pressure model of hemorrhagic shock was used as described previously.14
Briefly, after induction of anesthesia the left femoral artery was cannulated with polyethylene tubing (internal diameter 0.28 mm and external diameter 0.61 mm). Hemorrhagic shock was induced by blood withdrawal until mean arterial pressure (MAP) reached 30 mmHg; this blood pressure reduction was reached in approximately 11 min. An initial 0.5 ml of blood was withdrawn, followed by additional portions of about 0.1 ml until MAP reached 30 mmHg. The total amount of blood withdrawn was estimated from the number of portions taken from the animal. The blood was collected in a heparinized 1-ml syringe to prevent clotting. Hypotension at 30 mmHg was maintained during 90 min, with a continuous monitoring of MAP. Small increments of blood were infused or withdrawn during the shock period to maintain MAP at 30 mmHg. In both Shock groups, blood gas analysis was measured twice: Just after femoral cannulation (t = 0 min) and after the shock period immediately before killing (t = 90 min). In both Resuscitated groups, blood gas analysis was performed just after femoral cannulation (t = 0 min) and immediately before killing (t = 24 h). In the Sham groups, blood gas analysis was performed only immediately before killing (90 min) to avoid potential activation of endothelium and modification of vascular reactivity by withdrawal of blood at t = 0. After killing, the freshly isolated thoracic aorta was collected for in vitro
vasomotor studies. The abdominal aorta was removed and snap-frozen in liquid nitrogen without pretreatment with any drug, and stored at −80°C until analysis.
After removal, the descending thoracic aorta was immediately placed into cold physiologic saline. Freshly isolated thoracic aortic rings (1.5–2 mm in length) were mounted on two 200-μm stainless wires in the individual myograph baths wire myograph (Danish Myo Technology A/S, Aarhus, Denmark), containing 6 ml of Krebs solution, warmed to 37°C and bubbled continuously with 95% O2/5% CO2 to maintain pH at 7.4. The length of the aortic strips was assessed by microscopy. Aortic rings were equilibrated for 40 min until they were at a steady baseline. Then the rings were subjected twice to stimulation with potassium chloride (60 mm) to obtain reproducible contractile responses. Contraction was measured by obtaining concentration-response curves to phenylephrine (10 nm–100 μm). Endothelium-dependent relaxation was measured by obtaining concentration-response curves to acetylcholine (10 nm–300 μm) in rings precontracted with phenylephrine. The influence of vasoactive prostanoids on the response to acetylcholine was examined by incubating the rings with the nonspecific cyclooxygenase inhibitor indomethacine (10 μm) administered 20 min before application of phenylephrine. At the end of each experimental protocol, endothelium-independent relaxation was measured by applying the nitric oxide donor sodium nitroprusside (0.1 mm).
The methods used were described previously.15,16
Briefly, after grinding, the frozen aortas were placed in 300 μl of boiling 2% sodium dodecyl sulfate (SDS) followed by pounding by a polytron (Kinematica AG, Littau, Switzerland). Then the samples were centrifuged (4,000 revolutions per minute, 1 min) and boiled (95°C) for 5 min. After a second centrifugation (13,000 revolutions per minute, 3 min), supernatant was collected and used for measurements. Protein concentration was determined by Bio-Rad Protein Assay (Bio-Rad, Hercules, CA). Forty μg of total protein from each sample was separated on 4–20% Precise Protein Gels (Pierce, Rockford, IL) and transferred to nitrocellulose membranes. Anticyclooxygenase 1 antibody (ALEXIS Biochemicals, Lausen, Switzerland), anticyclooxygenase-2 antibody (BD Bioscience Pharmingen, San Diego, CA) and anti-β-actin (Sigma, St. Louis, MO) were used as a primary antibodies. Horseradish peroxidase-linked rabbit antimouse antibody was applied as a secondary antibody. Macrophage+IFNg/LPS (BD Bioscience Pharmingen) was used as a positive control for cyclooxygenase-2. The blots were analyzed using Super Signal assay (Pierce). β-actin served as a housekeeping protein. Cyclooxygenase-1 and cyclooxygenase-2 levels are expressed as ratios to β-actin protein levels.
Krebs solution was prepared freshly and of the following composition (mm): 120.4 NaCl, 5.9 KCl, 2.5 CaCl2, 1.2 MgSO4, 25.0 NaHCO3, 1.2 NaH2PO4, 11.5 glucose; these chemicals were obtained from Merck (Darmstadt, Germany). The following drugs were used: Acetylcholine chloride, phenylephrine, indomethacine, sodium nitroprusside, and NG-Monomethyl-L-arginine acetate salt. Stock solution (10 mm) for indomethacine was prepared in 96% ethanol. All other drugs were dissolved in deionized water. NG-Monomethyl-L-arginine acetate salt was purchased from MP Biomedicals (Illkirch, France). All other compounds were purchased from Sigma. The concentrations presented in the concentration-curve responses are expressed as a final molar concentration in the organ baths.
Data are presented as mean ± SD and n refers to the number of animals in the corresponding group. The contractile response to phenylephrine was expressed in mN, and relaxant responses to acetylcholine and sodium nitroprusside are expressed as a percentage of the preconstriction obtained with phenylephrine (0.1 mm). Concentration- response curves to phenylephrine and acetylcholine were characterized by area under the curve, the maximal response (Emax), and the negative logarithm of the molar concentration that caused half-maximal response (EC50). Concentration-response curves of individual rings were plotted with SigmaPlot version 10.0 (Systat Software Inc., San Jose, CA). EC50 was calculated by Four Parameter Logistic Curve (SigmaPlot) for each ring. Statistical analysis was done with SPSS 16.0.2 for Windows (SPSS Inc., Chicago, IL). Differences between concentration-response curves were evaluated by two-way repeated measures ANOVA followed by a Bonferroni test. Comparison of single parameters among multiple groups was done by one-way ANOVA followed by a Bonferroni test. Levene’s test was used to confirm the homogeneity of variance. The independent sample t test was used to compare the means of two groups where applicable. All tests were two-tailed, and differences were considered significant at P < 0.05.
Hemodynamic Changes and Routine Lab Parameters
To monitor the animals during the procedure, hemodynamic measurements and blood gas analyses were performed. After instrumentation at the start of the experimental protocol, hemodynamic parameters were comparable between the three experimental subgroups for a given type of anesthesia. In mice undergoing blood withdrawal, shock was confirmed by a significant drop in blood pressure; MAP varied between 26–36 mmHg during the 90-min shock period, followed by a near normalization to baseline values in resuscitated animals (fig. 1
). The main difference between both types of anesthesia was that in Sham isoflurane animals MAP was slightly lower (10 mmHg throughout the protocol) as compared with Sham isoflurane/nitrous oxide animals receiving adjunct nitrous oxide (P
Blood gases, pO2
, base excess, HCO3−
, hemoglobin, and hematocrit did not significantly differ between both Sham groups at all time points measured (table 1
). The pH was increased in the Shock isoflurane group, as compared with the Sham isoflurane group. Adjunct nitrous oxide resulted in a similar pH in the Sham isoflurane/nitrous oxide and Shock isoflurane/nitrous oxide groups (table 1
). During shock, pO2
was slightly increased in animals anesthetized with isoflurane only, as compared with the group with adjunct nitrous oxide (table 1
). Other blood gas parameters were similar in both Shock groups.
Experiments in vitro
were performed on freshly isolated aorta rings of similar length (P
= 0.1) in all groups (table 2
). Contractile responses of isolated aortic rings were obtained by constructing concentration-response curves to phenylephrine. The contractile response to phenylephrine in the Sham isoflurane/nitrous oxide group was enhanced (P
< 0.05) as compared with the Sham isoflurane group (fig. 2
). This enhancement was characterized by an increased Emax
< 0.05) and an unchanged EC50
= 0.2, table 3
). The contractile response to phenylephrine in the Shock isoflurane and Resuscitated isoflurane groups was also enhanced as compared with the Sham isoflurane group (P
< 0.05; fig. 2A
). This enhancement was also characterized by an increased Emax
< 0.05) and an unchanged EC50
= 0.7, table 3
). However, the contractile response to phenylephrine was identical between the Shock isoflurane and Shock isoflurane/nitrous oxide groups, and between the Resuscitated isoflurane and Resuscitated isoflurane/nitrous oxide groups (fig. 2
, no significant differences were observed in the Emax
values between the corresponding two groups (table 3
). These findings suggest that both shock and nitrous oxide increase contractility in a nonadditive manner.
Relaxation Responses to Acetylcholine
Administration of acetylcholine to aortic rings from mice subjected to sham conditions caused a biphasic response characterized by a relaxation, which was maximal at 0.3 μm, followed by a contractile response at concentrations ≥ 0.3 μm (Sham groups in fig. 3, A and B
). In Shock isoflurane and Resuscitated isoflurane mice, the contractile phase and hence the biphasic pattern in the concentration-response curve was fully suppressed (fig. 3A
). In contrast, adjunct nitrous oxide also preserved the biphasic pattern after conditions of shock and resuscitation (fig. 3B
). The latter is also reflected by the profound increase in acetylcholine concentration at which maximal relaxation was seen in Shock and Resuscitation groups that received anesthesia with isoflurane only (at 10 μm), as compared with groups with adjunct nitrous oxide (at 1 μm).
The biphasic pattern in the acetylcholine concentration-response curve was also abolished in the presence of indomethacine, an inhibitor of cyclooxygenase (fig. 3, C and D
). Consequently, under these conditions concentration-response curves for acetylcholine did not differ between groups. These findings imply the involvement of contractile prostaglandins in the upward stroke at higher concentrations of acetylcholine. Collectively, these findings indicate that the biphasic pattern of the response to acetylcholine after conditions of shock and resuscitation was maintained by adjunct nitrous oxide.
While groups differed in anesthetic regimes and the levels of phenylephrine precontraction, the relaxant response to sodium nitroprusside was similar in all groups (table 4
), suggesting that acetylcholine responses represent changes in endothelial cell function rather than altered vascular smooth muscle response to nitric oxide.
Vascular Cyclooxygenase-1 and Cyclooxygenase-2 Expression
Since short-term hemorrhagic shock differentially affected relaxation responses to acetylcholine with both modes of anesthesia, we subsequently investigated vascular protein expression of cyclooxygenase-1 and cyclooxygenase-2 in segments collected from the unstimulated abdominal aorta. In mice anesthetized with isoflurane only, vascular cyclooxygenase-1 expression decreased significantly after shock, followed by a recovery during resuscitation (fig. 4, A, B, and C
). In contrast, cyclooxygenase-1 expression was preserved in groups receiving adjunct nitrous oxide. A similar pattern was observed for vascular cyclooxygenase-2 expression, but changes did not reach statistical significance (fig. 4, A and B
). Collectively, these findings suggest that adjunct nitrous oxide mitigates the shock-induced decrease in the expression of cyclooxygenases, particularly cyclooxygenase-1.
We investigated the effects of nitrous oxide adjunct to anesthesia with isoflurane on vascular reactivity in an experimental model of shock in mice. Our data show that hemorrhagic shock in animals that received isoflurane during the procedure induced profound changes in the subsequent vascular reactivity of isolated thoracic rings, consisting of an increased contraction to phenylephrine and a loss of cyclooxygenase-mediated contraction to acetylcholine. These functional changes were accompanied by a decrease in the vascular expression of cyclooxygenase-1. Second, adjunct nitrous oxide augmented phenylephrine-induced contractility of Sham mice, but no further increase was observed when these animals underwent shock. In addition, adjunct nitrous oxide protected from the loss of contractile response to acetylcholine during shock and preserved the vascular expression of cyclooxygenase-1. Collectively, these findings suggest that vascular reactivity during different phases of shock may be preserved when adjunct nitrous oxide is employed, which may involve (among others) a preservation of vascular cyclooxygenase expression.
In this study, we investigated the effect of different anesthetic techniques applied during hemorrhagic shock in vivo on the vascular properties of aortic tissue that was harvested subsequently and examined in the absence of anesthetics. To our knowledge, the influence of anesthetics on vascular reactivity has not been explored in this way before. Importantly, the changes observed in vascular reactivity in the shock group under isoflurane anesthesia imply that this procedure induces protracted changes in the vascular bed. Indeed, such view is in keeping with the observed down-regulation of cyclooxygenase-1 in this group.
Systemic hypotension after isoflurane anesthesia has been reported previously,4,12,17
and its general depressant effects on hemodynamics are quite notorious indeed.10
It may represent an important unwanted side effect of anesthesia, particularly during conditions of shock in which tissue perfusion is already at threat. Investigation of the underlying mechanisms was not within the scope of this study, but previous studies reported the involvement of decrements in processes such as myofilament calcium sensitivity, intracellular calcium concentration, or voltage-gated calcium influx,18–24
all of which might have contributed to decreased contractility after anesthesia. In this study, decreased arterial pressure was observed together with decreased constriction to phenylephrine in isolated aortic ring preparation obtained from Sham mice anesthetized with isoflurane, as compared to those receiving adjunct nitrous oxide. Recently, Pypendop et al.
showed that addition of 70% nitrous oxide to isoflurane anesthesia results in improved arterial and central venous pressures.12
In addition, a study in patients under sevoflurane anesthesia suggests that adjunct nitrous oxide normalizes hemodynamic parameters of regional and systemic flow.11
These findings suggest that hemodynamics may be better preserved during adjunct anesthesia with nitrous oxide, as compared with monoanesthesia with isoflurane. It should also be noted, however, that shock increased constriction to phenylephrine. It thus appears that contractile mechanisms become mobilized to maintain perfusion pressure during shock and overrule the effect of anesthesia. In keeping with that, contractility to phenylephrine was not further increased after shock with adjunct nitrous oxide, indicating that the effect of nitrous oxide was not additive.
Vascular responsiveness was also investigated by studying endothelial-mediated responses. As reported previously,25
administration of acetylcholine caused relaxation at low concentrations and contraction at higher concentrations, thus generating a biphasic concentration-response curve. Preincubation with indomethacine fully abolished the normal upward stroke in the concentration-response curve, thus indicating the involvement of contractile prostaglandins derived from cyclooxygenase herein. Interestingly, the upward stroke in the concentration-response curve was also lost in aorta preparations of shock-mice anesthetized with isoflurane, but not in those receiving adjunct nitrous oxide. Such findings suggest that shock may alter the production of contractile prostaglandins, which may be preserved during anesthesia with adjunct nitrous oxide. In mouse aorta, endothelial denudation abolishes the acetylcholine-mediated contractile responses,25
implicating that contractile cyclooxygenases metabolites are derived from endothelial cells. In turn, this would implicate that the decreased cyclooxygenase-1 expression as observed after shock is caused by down-regulation of the enzyme in endothelial cells. Previous studies suggest both isoforms of cyclooxygenase to be expressed in aorta endothelial and/or vascular smooth muscle cells,26,27
and that both cyclooxygenase-1 and cyclooxygenase-2 may be involved in production of contractile prostaglandins. At present, there are few data on the influence of isoflurane on cyclooxygenase-protein expression. It has been reported that isoflurane produces cyclooxygenase-2 mediated anesthetic preconditioning, but it did not affect cyclooxygenase-1 and cyclooxygenase-2 protein expression.28,29
Taken together, our results indicate that the loss of acetylcholine-induced contractile function in Shock mice anesthetized solely with isoflurane is because of decreased endothelial production of contractile prostaglandins caused by down-regulation of endothelial cyclooxygenase-1. Moreover, adjunct nitrous oxide counteracts these changes, most likely because of a preservation of normal endothelial function.
Alternatively, nitrous oxide-evoked hyperhomocysteinemia may offer an explanation for enhanced vascular reactivity to phenylephrine in Sham animals, because of an increase in asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase.30
Asymmetric dimethylarginine has been reported to increase arteriolar basal tone31
and participate in the maintenance of vasospasm.32
Previously, nitrous oxide anesthesia has been shown to enhance homocysteine concentration and impairment of endothelial function.33
However, acetylcholine-evoked relaxation of groups with and without nitrous oxide was similar in the presence of indomethacine; i.e.
, upon blockade of prostaglandin synthesis. Consequently, nitric oxide–mediated relaxation does not differ between both groups, making the involvement of hyperhomocysteinemia unlikely.
Furthermore, nitrous oxide was reported to stimulate the sympathetic nervous system, which induces systemic and local vasoconstriction. This effect possibly explains the increased MAP during anesthesia with nitrous oxide.34
Whether this phenomenon also explains the normalization of phenylephrine-mediated contraction in resuscitated animals from the nitrous oxide group remains to be established.
Aortic rings were studied in the absence of anesthetics in the organ bath. Our study clearly demonstrates vasomotor changes and decreased expression of cyclooxygenase-1 in the postshock period, which were prevented by the use of nitrous oxide during the shock period. In view of the absence of volatile anesthetics and nitrous oxide in the organ baths, these results likely reflect vascular changes present in the immediate postshock period; e.g., at the postanesthesia care unit or intensive care unit. However, it is unknown how these results obtained in isolated arteries correspond to vasoreactivity in in vivo conditions. Further, isoflurane and isoflurane/nitrous oxide groups differed in depth of anesthesia, since equivalent concentrations of isoflurane were used. However, as the study aimed to evaluate the effect of adjunct nitrous oxide, we chose to use the same isoflurane concentration in all experimental groups. Also, because the blood volume withdrawn for the induction of hemorrhagic shock was not assessed, we cannot comment on possible intraoperative differences in circulating volume. Finally, as the number of experiments was about six, small differences in calculated parameters of acetylcholine and phenylephrine-mediated responsiveness, or of cyclooxygenase expression may have been unnoticed.
Nowadays, despite intensive scientific discussion on the influence of adjunct nitrous oxide to volatile anesthesia,33–38
only few experimental data regarding this question are available. The present study shows positive effects of adjunct nitrous oxide on vasoresponsiveness after short-term hemorrhagic shock in mice, since this anesthetic agent normalized vascular reactivity after as observed under isoflurane anesthesia.
In summary, the findings of this study show that vascular reactivity after hemorrhagic shock is affected by the choice of general anesthesia. Short-term hemorrhagic shock under isoflurane anesthesia increased phenylephrine-mediated contractile response and suppressed the acetylcholine-evoked contractile effect in thoracic mouse aorta, while adjunct nitrous oxide may attenuate changes in vascular reactivity caused by hemorrhagic shock and/or subsequent resuscitation. The results of this study also indicate that cyclooxygenase proteins participate in shock-dependent changes of vasoresponsiveness to acetylcholine. Our data suggest that the choice of the anesthetic regimen during emergency surgery for hemorrhagic shock may influence postsurgery vascular reactivity.
The authors thank Bernadet D.M. Meijering, M.Sc., Research Fellow, Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, for the expert technical consultation.
1. Keel M, Trentz O: Pathophysiology of polytrauma. Injury 2005; 36:691–709
2. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588–95
3. Musser JB, Bentley TB, Griffith S, Sharma P, Karaian JE, Mongan PD: Hemorrhagic shock in swine: Nitric oxide and potassium sensitive adenosine triphosphate channel activation. Anesthesiology 2004; 101:399–408
4. Baumert JH, Hecker KE, Hein M, Reyle-Hahn SM, Horn NA, Rossaint R: Haemodynamic effects of haemorrhage during xenon anaesthesia in pigs. Br J Anaesth 2005; 94:727–32
5. Xu J, Liu L: The role of calcium desensitization in vascular hyporeactivity and its regulation after hemorrhagic shock in the rat. Shock 2005; 23:576–81
6. Park WK, Kim MH, Ahn DS, Chae JE, Jee YS, Chung N, Lynch C: Myocardial depressant effects of desflurane: Mechanical and electrophysiologic actions in vitro. Anesthesiology 2007; 106:956–66
7. Akata T: General anesthetics and vascular smooth muscle: Direct actions of general anesthetics on cellular mechanisms regulating vascular tone. Anesthesiology 2007; 106:365–91
8. Akata T, Kanna T, Yoshino J, Takahashi S: Mechanisms of direct inhibitory action of isoflurane on vascular smooth muscle of mesenteric resistance arteries. Anesthesiology 2003; 99:666–77
9. Izumi K, Akata T, Takahashi S: Role of endothelium in the action of isoflurane on vascular smooth muscle of isolated mesenteric resistance arteries. Anesthesiology 2001; 95:990–8
10. Hopkins PM: Nitrous oxide: A unique drug of continuing importance for anaesthesia. Best Pract Res Clin Anaesthesiol 2005; 19:381–9
11. Kaisti KK, Långsjö JW, Aalto S, Oikonen V, Sipilä H, Teräs M, Hinkka S, Metsähonkala L, Scheinin H: Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 2003; 99:603–13
12. Pypendop BH, Ilkiw JE, Imai A, Bolich JA: Hemodynamic effects of nitrous oxide in isoflurane-anesthetized cats. Am J Vet Res 2003; 64:273–8
13. Sanders RD, Weimann J, Maze M: Biologic effects of nitrous oxide: A mechanistic and toxicologic review. Anesthesiology 2008; 109:707–22
14. van Meurs M, Wulfert FM, Knol AJ, De Haes A, Houwertjes M, Aarts LP, Molema G: Early organ-specific endothelial activation during hemorrhagic shock and resuscitation. Shock 2008; 29:291–9
15. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, Chambon P, Bayard F, Arnal JF: Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res 2002; 90:413–9
16. Potenza MA, Botrugno OA, De Salvia MA, Lerro G, Nacci C, Marasciulo FL, Andriantsitohaina R, Mitolo-Chieppa D: Endothelial COX-1 and -2 differentially affect reactivity of MVB in portal hypertensive rats. Am J Physiol Gastrointest Liver Physiol 2002; 283:G587–94
17. Conzen PF, Vollmar B, Habazettl H, Frink EJ, Peter K, Messmer K: Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992; 74:79–88
18. Akata T: Cellular and molecular mechanisms regulating vascular tone. Part 2: Regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells. J Anesth 2007; 21:232–42
19. Stekiel TA, Contney SJ, Kokita N, Bosnjak ZJ, Kampine JP, Stekiel WJ: Mechanisms of isoflurane-mediated hyperpolarization of vascular smooth muscle in chronically hypertensive and normotensive conditions. Anesthesiology 2001; 94:496–506
20. Stekiel TA, Kokita N, Yamazaki M, Bosnjak ZJ, Kampine JP, Stekiel WJ: Effect of isoflurane on in situ vascular smooth muscle transmembrane potential in spontaneous hypertension. Anesthesiology 1999; 91:207–14
21. Kokita N, Stekiel TA, Yamazaki M, Bosnjak ZJ, Kampine JP, Stekiel WJ: Potassium channel-mediated hyperpolarization of mesenteric vascular smooth muscle by isoflurane. Anesthesiology 1999; 90:779–88
22. Li T, Liu L, Xu J, Yang G, Ming J: Changes of Rho kinase activity after hemorrhagic shock and its role in shock-induced biphasic response of vascular reactivity and calcium sensitivity. Shock 2006; 26:504–9
23. Li T, Liu L, Liu J, Ming J, Xu J, Yang G, Zhang Y: Mechanisms of Rho kinase regulation of vascular reactivity following hemorrhagic shock in rats. Shock 2008; 29:65–70
24. Liu LM, Ward JA, Dubick MA: Hemorrhage-induced vascular hyporeactivity to norepinephrine in select vasculatures of rats and the roles of nitric oxide and endothelin. Shock 2003; 19:208–14
25. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL: Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 2005; 289:H1027–32
26. Li M, Kuo L, Stallone JN: Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am J Physiol Heart Circ Physiol 2008; 294:H2444–55
27. Kawka DW, Ouellet M, Hétu PO, Singer II, Riendeau D: Double-label expression studies of prostacyclin synthase, thromboxane synthase and COX isoforms in normal aortic endothelium. Biochim Biophys Acta 2007; 1771:45–54
28. Alcindor D, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo. Anesthesiology 2004; 100:547–54
29. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC: Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: Role of cyclooxygenase-2. Anesthesiology 2004; 100:525–31
30. Dayal S, Lentz SR: ADMA and hyperhomocysteinemia. Vasc Med 2005; 10:S27–33
31. Toth J, Racz A, Kaminski PM, Wolin MS, Bagi Z, Koller A: Asymmetrical Dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. Hypertension 2007; 49:563–8
32. Pluta RM, Oldfield EH: Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. Rev Recent Clin Trials 2007; 2:59–67
33. Myles PS, Chan MT, Kaye DM, McIlroy DR, Lau CW, Symons JA, Chen S: Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology 2008; 109:657–63
34. Jahn UR, Berendes E: Nitrous oxide–an outdated anaesthetic. Best Pract Res Clin Anaesthesiol 2005; 19:391–7
35. Nagele P, Zeugswetter B, Wiener C, Burger H, Hüpfl M, Mittlböck M, Födinger M: Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology 2008; 109:36–43
36. Myles PS, Leslie K, Chan MT, Forbes A, Paech MJ, Peyton P, Silbert BS, Pascoe E; ENIGMA Trial Group: Avoidance of nitrous oxide for patients undergoing major surgery: A randomized controlled trial. Anesthesiology 2007; 107:221–31
37. Preckel B, Bolten J: Pharmacology of modern volatile anaesthetics. Best Pract Res Clin Anaesthesiol 2005; 19:331–48
38. Mashour GA, Forman SA, Campagna JA: Mechanisms of general anesthesia: From molecules to mind. Best Pract Res Clin Anaesthesiol 2005; 19:349–64
This article has been cited 2 time(s).
American Journal of Physiology-Heart and Circulatory PhysiologyGrowth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endotheliumAmerican Journal of Physiology-Heart and Circulatory Physiology
AnesthesiologyDoes Correcting the Numbers Improve Long-term Outcome?Anesthesiology
© 2009 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.